Parallel Advisors »

Vor Biopharma shares owned by Parallel Advisors

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $855 48 17.83

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Victoryshares Free Cash Flow Etf Etf (VFLO)

View all positions for Parallel Advisors

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma